Clinical Trial Detail

NCT ID NCT01579994
Title Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors Memorial Sloan Kettering Cancer Center.
Indications

lung adenocarcinoma

Therapies

Crizotinib + Ganetespib

Age Groups: adult

Additional content available in CKB BOOST